MedElevator Войти в исследования
← Поиск публикаций
Медицинская библиотека · The Malaysian journal of pathology · 2018

Autologous mononuclear cells from different sources are seen to improve wound healing in patients with haematological malignancies.

Wan Jamaludin W F, Mohamad Yusoff F, Ismail N A, Mohd Idris M R, Palaniappan S, Ng C K K, Abdullah N, Zaider S Z A, Abdul Wahid S F S

Клинический случайСтатьяПеревод в очереди

Аннотация

INTRODUCTION

Immunosuppressive state due to haematological malignancies and chemotherapy may cause disruption to wound healing despite optimum conventional treatment and standard wound dressing. Non-healing wounds are predisposed to infection whereas chemotherapy dose reductions or interruptions are associated with poor survival.

BACKGROUND

Mononuclear cells contain progenitor cells including haematopoietic and mesenchymal stem cells, endothelial progenitor cells and fibroblasts which facilitate wound healing through cytokines, growth factor secretions, cell-cell interactions and provision of extracellular matrix scaffolding. Clinical applications of autologous mononuclear cells therapy in wound healing in non-malignant patients with critical limb ischaemia have been reported with remarkable outcome.

METHODS

We report three patients with haematological malignancies undergoing chemotherapy, who received autologous mononuclear cells implantation to treat non-healing wound after optimum conventional wound care. The sources of mononuclear cells (MNC) were from bone marrow (BM), peripheral blood (PB) and mobilised PB cells (mPB-MNC) using granulocyte colony stimulating factor (G-CSF). The cells were directly implanted into wound and below epidermis. Wound sizes and adverse effects from implantation were assessed at regular intervals.

RESULTS

All patients achieved wound healing within three months following autologous mononuclear cells implantation. No implantation adverse effects were observed.

CONCLUSIONS

Autologous mononuclear cells therapy is a feasible alternative to conventional wound care to promote complete healing in non-healing wounds compounded by morbid factors such as haematological malignancies, chemotherapy, diabetes mellitus (DM), infections and prolonged immobility.

Для цитирования: Wan Jamaludin W F, Mohamad Yusoff F, Ismail N A, Mohd Idris M R, Palaniappan S, Ng C K K, Abdullah N, Zaider S Z A, Abdul Wahid S F S. Autologous mononuclear cells from different sources are seen to improve wound healing in patients with haematological malignancies.. The Malaysian journal of pathology. 2018.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.